Healthcare
Sky Century Investment, Inc.(SKYI)
Live Price
Offline$0.6058
+0.00% today
1Y Change
+138.50%
Window
Jun 23, 2025 โ Jun 8, 2026
- Market Cap
- โ
- Revenue Growth
- +147.0%
- EPS Growth
- +37.5%
- Dividend Yield
- 0.0%
Coverage: 241 bars ยท Jun 23, 2025 โ Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sky Century Investment, Inc. (SKYI) is a Healthcare stock with listed on OTC. The stock last traded around $0.61 and up 138.5% across the available one-year price window (Jun 23, 2025 โ Jun 8, 2026). Baseline metrics include revenue growth of +147.0%, EPS growth of +37.5%, a dividend yield of 0.0%. What stands out right now is revenue +147.0%, EPS +37.5%, free cash flow +391.7% with operating margin -59.9% and ROIC 23.1%. Valuation is more restrained than many high-expectation growth names at price/sales 4.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SKYI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+147.0% vs +7.6% peer median
Operating Margin
Below sector median
-59.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Nov 30, 2023, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +147.0% and EPS at +37.5%, with operating margin around -59.9%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKYI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SKYI Max Drawdown
-84.59%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SKYI and SPY.
Company Overview
Sky Century Investment, Inc.
Other OTC
Sky Century Investment, Inc. engages in selling cannabidiol products using pharmaceutical grade ingredients. The company also provides a range of online services in the field of digital marketing, strategy, planning, SEO, analytics, and reporting. In addition, it is involved in the provision of content and website development, and mail marketing services for companies involved in the production of CBD products. The company was incorporated in 2012 and is based in Las Vegas, Nevada.
- Leadership
- Nataliia Petranetska
- IPO Date
- Nov 3, 2014
- Employees
- 1
- Street Address
- 220 Emerald Vista Way
- Mailing
- Las Vegas, NV, 89144
- Region
- Las Vegas, NV, US
- Reporting Currency
- USD
- Investor Line
- 205-238-7735
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 4.0
- Price/Book
- โ
Growth
- Revenue
- +147.0%
- EPS
- +37.5%
- Free Cash Flow
- +391.7%
Profitability
- Gross Margin
- 49.8%
- Operating Margin
- -59.9%
- Net Margin
- -59.9%
- ROE
- 24.6%
- ROIC
- 23.1%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.01
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.